Spyre Therapeutics Announces Grants of Inducement Awards

WALTHAM, Mass., March 1, 2024 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a development-stage biotechnology company advancing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for the treatment...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news